GLP-1 medications , or glucagon-like peptide-1 receptor agonists , represent a substantial development in how we approach type 2 diabetes . These injectable therapies function to imitating the body’s https://emiliaducu834986.blogpayz.com/42237608/glp-1-a-major-approach-in-blood-sugar-treatment